These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22543314)

  • 21. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Aug; 60(30):1018-9. PubMed ID: 21814165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningococcal Disease: Vaccines-Who's at Risk and the Future.
    O'Malley PA
    Clin Nurse Spec; 2018; 32(1):15-18. PubMed ID: 29200035
    [No Abstract]   [Full Text] [Related]  

  • 23. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Travelers' protection against meningococcal disease: a new vaccine option.
    Black S
    J Travel Med; 2010; 17 Suppl():18-25. PubMed ID: 20849429
    [No Abstract]   [Full Text] [Related]  

  • 25. Effectively introducing a new meningococcal A conjugate vaccine in Africa: the Burkina Faso experience.
    Djingarey MH; Barry R; Bonkoungou M; Tiendrebeogo S; Sebgo R; Kandolo D; Lingani C; Preziosi MP; Zuber PL; Perea W; Hugonnet S; Dellepiane de Rey Tolve N; Tevi-Benissan C; Clark TA; Mayer LW; Novak R; Messonier NE; Berlier M; Toboe D; Nshimirimana D; Mihigo R; Aguado T; Diomandé F; Kristiansen PA; Caugant DA; Laforce FM
    Vaccine; 2012 May; 30 Suppl 2():B40-5. PubMed ID: 22607898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can we defeat meningococcal disease in low and middle income countries?
    Greenwood B; Chiarot E; MacLennan CA; O'Ryan M
    Vaccine; 2012 May; 30 Suppl 2():B63-6. PubMed ID: 22607901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Meningococcal vaccine. Editorial].
    Gendrel D; Cohen R
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S47-8. PubMed ID: 22883365
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2-10 years of age.
    Black S; Klein NP; Shah J; Bedell L; Karsten A; Dull PM
    Vaccine; 2010 Jan; 28(3):657-63. PubMed ID: 19895922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
    Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical inquiries. What are the indications for meningococcal vaccination?
    Moye P; Edgerton L; Flake D; Stephens M
    J Fam Pract; 2007 May; 56(5):396-8. PubMed ID: 17475173
    [No Abstract]   [Full Text] [Related]  

  • 31. [
    Boccalini S; Panatto D; Mennini FS; Marcellusi A; Bini C; Amicizia D; Lai PL; Micale RT; Frumento D; Azzari C; Ricci S; Bonito B; DI Pisa G; Iovine M; Lodi L; Giovannini M; Moscadelli A; Paoli S; Pennati BM; Pisano L; Bechini A; Bonanni P
    J Prev Med Hyg; 2021 Mar; 62(1 Suppl 1):E1-E128. PubMed ID: 34622076
    [No Abstract]   [Full Text] [Related]  

  • 32. Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine.
    Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices
    MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(31):794-5. PubMed ID: 17694617
    [No Abstract]   [Full Text] [Related]  

  • 33. Meningococcal C conjugate vaccination recommendations for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Nov; 33(ACS-11):1-12. PubMed ID: 18064747
    [No Abstract]   [Full Text] [Related]  

  • 34. Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).
    Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 May; 57(17):462-5. PubMed ID: 18451758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines].
    D'Ancona F; Alfonsi V; Ciofi degli Atti ML
    Ig Sanita Pubbl; 2006; 62(5):483-92. PubMed ID: 17206224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The changing and dynamic epidemiology of meningococcal disease.
    Halperin SA; Bettinger JA; Greenwood B; Harrison LH; Jelfs J; Ladhani SN; McIntyre P; Ramsay ME; Sáfadi MA
    Vaccine; 2012 May; 30 Suppl 2():B26-36. PubMed ID: 22178525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of the National Meningococcal C Vaccination Program.
    Cohen NJ
    Commun Dis Intell Q Rep; 2003; 27(2):161-2. PubMed ID: 12926730
    [No Abstract]   [Full Text] [Related]  

  • 38. Few university students from overseas have been vaccinated against meningococcal infection.
    Edmunds MR; Davidson JE; Wood AL; Raichura V
    BMJ; 2001 Jan; 322(7278):102. PubMed ID: 11154644
    [No Abstract]   [Full Text] [Related]  

  • 39. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
    [No Abstract]   [Full Text] [Related]  

  • 40. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
    Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
    Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.